Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03705013 · ClinicalTrials.gov registry record

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

A clinical trial, sponsored by Exact Sciences Corporation.

Terminated
Registry status
51
Enrollment target

NCT03705013 is a clinical trial that was terminated before completion, run by Exact Sciences Corporation. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03705013 was terminated before completion, sponsored by Exact Sciences Corporation.

TERMINATED
Registry status
51 participants
Enrollment target

Study Summary

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

Interventions

  • OTHER Cologuard

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2018-10-30
Est. Completion 2019-11-16

Sponsor

Exact Sciences Corporation

30 total trials

What the Registry Record Tells You About NCT03705013

The ClinicalTrials.gov registry entry for NCT03705013 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cologuard is the first listed.

NCT03705013 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03705013 about?

NCT03705013 is a clinical study titled "Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)". The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

What is the current status of trial NCT03705013?

This trial is currently terminated. The enrollment target is 51 participants. The study started on 2018-10-30. Estimated completion is 2019-11-16.

What interventions are being tested in trial NCT03705013?

The interventions under investigation include: Cologuard (OTHER).

Who is sponsoring clinical trial NCT03705013?

This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.